These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18481037)

  • 1. Azathioprine prescribing in neurology.
    Goldsmith P; Lennox G; Bhalla N
    J Neurol; 2008 Jun; 255(6):791-5. PubMed ID: 18481037
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
    Rawoot A; Little F; Heckmann JM
    S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term, low-dose immunosuppression for myasthenia does not affect collateral, asymptomatic sclerosing cholangitis.
    Finsterer J; Höflich S
    Arq Neuropsiquiatr; 2012 Feb; 70(2):158-9. PubMed ID: 22311226
    [No Abstract]   [Full Text] [Related]  

  • 4. [Azathioprine also in chronic active ulcerative colitis. Brake pedal for the immune system].
    MMW Fortschr Med; 2000 Mar; 142(12):58-9. PubMed ID: 10804723
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease.
    Stocco G; Martelossi S; Decorti G; Bartoli F; Ventura A
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1083-4; author reply 1084-5. PubMed ID: 17877516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autoimmune hepatitis].
    Manns MP; Strassburg CP
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():39-42. PubMed ID: 12467006
    [No Abstract]   [Full Text] [Related]  

  • 7. Nursing implications of immunosuppression in transplantation.
    Shaefer M; Williams L
    Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When is too much enough?
    Mayer L
    Gastroenterology; 2006 Apr; 130(4):1352-4. PubMed ID: 16618427
    [No Abstract]   [Full Text] [Related]  

  • 9. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's disease.
    Karaahmet F; Akinci H; Ayte R; Hamamci M; Coskun Y; Yuksel I
    J Crohns Colitis; 2013 Oct; 7(9):e404. PubMed ID: 23623283
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
    Thakur BK; Bernardi DM; Murali MR; McClain SA; Clark RA
    J Am Acad Dermatol; 1998 Mar; 38(3):488-90. PubMed ID: 9520034
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenic littoral cell hemangioendothelioma in a patient with Crohn's disease previously treated with immunomodulators and anti-TNF agents: a rare tumor linked to deep immunosuppression.
    Cappello M; Bravatà I; Cocorullo G; Cacciatore M; Florena AM
    Am J Gastroenterol; 2011 Oct; 106(10):1863-5. PubMed ID: 21979217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacillus cereus bacteremia in Crohn's disease with multiple ileal stricture on maintenance azathioprine therapy].
    Hizawa K; Nagata Y; Taniguchi M; Nakamori M; Matsumoto T; Iida M
    Nihon Shokakibyo Gakkai Zasshi; 2009 Jan; 106(1):56-60. PubMed ID: 19122422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine can be safely used in HIV-infected individuals.
    Chamberlain FE; Dinani N; Jagjit Singh GK; Bower M; Nelson M
    AIDS; 2014 Jan; 28(3):447-8. PubMed ID: 24670528
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic tissue damage and immunosuppression].
    Holm O
    Lakartidningen; 1976 Apr; 73(17):1624-8. PubMed ID: 1083468
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
    Hinrichsen H; Fölsch UR
    Internist (Berl); 1999 Mar; 40(3):327-8. PubMed ID: 10205763
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined immunosuppression in high-risk patients with IgA nephropathy?
    Floege J; Eitner F
    J Am Soc Nephrol; 2010 Oct; 21(10):1604-6. PubMed ID: 20829408
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignancy after immunosuppressive therapy.
    Mazzei D; Polli EE; Quarto di Palo F
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):197. PubMed ID: 326275
    [No Abstract]   [Full Text] [Related]  

  • 19. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn's disease.
    Wonders J; De Boer NK; Van Weyenberg SJ
    J Crohns Colitis; 2012 Jun; 6(5):636. PubMed ID: 22402255
    [No Abstract]   [Full Text] [Related]  

  • 20. The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
    D'Amico E; Leone C; Graziano G; Amato MP; Bergamaschi R; Cavalla P; Coniglio G; Di Battista G; Ferrò MT; Granella F; Granieri E; Lugaresi A; Lus G; Millefiorini E; Pozzilli C; Tedeschi G; Zappia M; Comi G; Trojano M; Lepore V; Patti F
    PLoS One; 2016; 11(6):e0157721. PubMed ID: 27348606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.